Skip to main content
SpringerLink
Log in

Differences Between in Vitro and in Vivo Sensitivity of Campylobacter pylori to Antibacterials

  • Conference paper
Campylobacter pylori

Abstract

The spiral bacteria isolated from the gastric mucosa in 1982 in Western Australia were originally called Campylobacter pyloridis [15] but this specific epithet was technically inappropriate, and the name has since been revised to C. pylori [12].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armstrong JA, Wee SH, Goodwin CS, Wilson DH (1987) Response of Campylobacter pyloridis to antibiotics, bismuth and an acid–reducing agent in vitro. An ultrastructural study. J Med Microbiol 24:343–350

    CAS  Google Scholar 

  2. Borody TJ, Carrick J, Hazell SL (1987) Symptoms improve after the eradication of gastric Campylobacter pyloridis. Med J of Aust 146:450–451

    CAS  Google Scholar 

  3. Chen XG, Correa P, Offerhaus J, Rodriguez E, Janney F, Hoffmann E, Fox J, Hunter F, Diavolitsis S (1986) Ultrastructure of the gastric mucosa harboring Campylobacter–like organisms. Amer J Clin Path 86:575 – 582

    CAS  Google Scholar 

  4. Czinn S, Carr H, Aronoff S (1986) Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, rosithromycin [RU28965], CP62993) and rifampicin. Antimicrob Agents Chemother 30:328–329

    CAS  Google Scholar 

  5. Glupczynski Y, Labbe M, Burette A, Delmee M, Avesani V, Bruck C (1987) Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet i: 1096

    Article  Google Scholar 

  6. Goodwin CS, Armstrong JA, Marshall BJ (1986) Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 39:353–365

    Article  CAS  PubMed  Google Scholar 

  7. Goodwin CS, Blake P, Blincow E (1986) The minimum inhibitory and bactericidal concentrations of antibiotic and anti–ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 17:309–314

    Article  CAS  PubMed  Google Scholar 

  8. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackburn S, Phillips M (1987) Prevention of nitroimidazole resistance in Campylobacter pylori by co–administration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 41:207–210

    Article  Google Scholar 

  9. Jacobs RF, Wilson CB (1983) Intracellular penetration and antimicrobial activity of antibiotics. J Antimicrob Chem 12: C, 13–20

    CAS  Google Scholar 

  10. Lambert T, Megraud F, Gerbaud G, Courvalin P (1986) Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Age and Chemother 30:510–511

    CAS  Google Scholar 

  11. Langenberg ML, Rauws EAJ, Schipper MEI, Widjojokosumo GN, Tytgat J, Rietra PJGM, Zanen HC (1985) The pathogenic role of Campylobacter pyloridis studied by attempts to eliminate these organisms. Campylobacter III: Proceedings of the third international workshop on Campylobacter infections. London: Public Health Laboratory Service 162–163

    Google Scholar 

  12. Marshall BJ, Goodwin CS (1987) Revised nomenclature for Campylobacter pyloridis. Internat J Systemat Bacteriol 37:68

    Article  Google Scholar 

  13. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i: 1311 –1315 14. Marshall BJ, Armstrong JA, Francis GJ, Nokes NT, Wee SH (1987) The antibacterial action of bismuth in relation to Campylobacter pyloridis colonisation and gastritis. Digestion 37: Supp. 2,16–30

    Google Scholar 

  14. Marshall BJ, Royce H, Annear DI, Goodwin CS, Pearman JW, Warren JR and Armstrong JA (1984) Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Letters 25:83–88

    Google Scholar 

  15. McNulty CAM, Dent J, Wise R (1985) Susceptibility of clinical isolates of Campylobacter pyloridis to eleven antimicrobial agents. Antimicrob Agents Chemother 28:837–838

    CAS  PubMed  Google Scholar 

  16. McNulty CAM, Gearty JC, Grump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R (1986) Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Brit Med J 293:645–649

    Article  CAS  Google Scholar 

  17. Taylor DE, Hargreaves JA, Ng LK, Sherbaniuk RW, Jewell LD (1987) Isolation and characterization of Campylobacter pyloridis from gastric biopsies. J Clin Pathol 87:49–54

    CAS  Google Scholar 

  18. Tricottet V, Bruneval P, Vire O, Camilleri JP, Bloch F, Bonte N, Roge J (1986) Campylobacter–like organisms and surface epithelium abnormalities in active chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 10:113–122

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. C. S. Goodwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. Armstrong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. H. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II, Krankenanstalten der Stadt Remscheid, Akademisches Lehrkrankenhaus der Universität Bonn, Hans-Potyka-Straße 28, 5630, Remscheid 11, Germany

    H. Menge

  2. Universitätsklinikum Steglitz, Freie Universität Berlin, Hindenburgdamm 30, 1000, Berlin 45, Germany

    M. Gregor

  3. Department of Gastroentero-Hepatology, Academisch Medisch Centrum , Academisch Ziekenhuis bij de Universiteit van Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    G. N. J. Tytgat

  4. Division of Gastroenterology, Department of Internal Medicine, University of Virginia, Box 145, Charlottesville, VA, 22908, USA

    B. J. Marshall

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Goodwin, C.S., Armstrong, J.A., Wilson, D.H. (1988). Differences Between in Vitro and in Vivo Sensitivity of Campylobacter pylori to Antibacterials. In: Menge, H., Gregor, M., Tytgat, G.N.J., Marshall, B.J. (eds) Campylobacter pylori. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83322-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83322-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83324-3

  • Online ISBN: 978-3-642-83322-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation